ASLAN Pharmaceuticals Earning Date (ASLN)

USA |NASDAQ |USD |ADR

ASLN Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Aug 6, 2022 (est) Jun 30, 2022 - - $-0.11
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Aug 6, 2022 (est) Jun 30, 2022 - $0.00 $0.00

Aslan Pharmaceuticals's next estimated earnings date (based on same quarter last year's date) is Aug 6, 2022 for the fiscal quarter ending Jun 30, 2022.

ASLN Earnings Date & History Chart

ASLN Earnings & Revenue Forecast

ASLN Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Jun 2022 1 $-0.20 $-0.20 $-0.20
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 3 $-0.56 $-0.79 $-0.42
Dec 2023 2 $-0.95 $-1.41 $-0.50

ASLN Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Jun 2022 0 / 1 $-0.17 $-0.17 $-0.17
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 0 / 1 $-0.53 $-0.53 $-0.53
Dec 2023 0 / 0 $-0.50 $-0.50 $-0.50

ASLN Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Jun 2022 1 $0.00 $0.00 $0.00
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 3 $0.00 $0.00 $0.00
Dec 2023 2 $0.00 $0.00 $0.00

ASLN Earnings Date & Revenue History

ASLN Earnings History

|
Show More
Show More

ASLN Revenue History

|
Show More
Show More

Aslan Pharmaceuticals Next Earnings Date & Report

ASLN Apr 2022 (FQ) Earnings Date & Report Preview

ASLN's next estimated earnings date (based on same quarter last year's report date) is Aug 6, 2022 for the fiscal quarter ending Jun 30, 2022.

Aslan Pharmaceuticals Previous Earnings Dates & Reports

ASLN Previous Earnings Date & Report Recap: Mar 2022 (FQ)

Aslan Pharmaceuticals's previous earnings date was Apr 28, 2022 for its fiscal quarter ended Mar 31, 2022.

Revenues were $0.00.

The company reported a net income of $-12.94M.

ASLN Previous Earnings Date & Report Recap: Dec 2021 (FY)

Aslan Pharmaceuticals's previous annual earnings date was Mar 25, 2022 for its fiscal year ended Dec 31, 2021.

ASLN's earnings per share (EPS) was $-0.54, missing the consensus analysts forecast of $-0.48 by 12.75% , and lower than the previous year's EPS (Dec 2020) by 20.27%.

Revenues were $0.00.

The company reported a net income of $-31.32M.

Aslan Pharmaceuticals reported a free cash flow of $-34.04M for its fiscal year, compared to $-15.06M a year ago.

The company ended the fiscal year with $31.06M in total debt, an increase of 63.68% compared to the previous year.